December 11,2020
New Project Dynamics ｜ E-nitiate Biopharmaceuticals Settlement and Betta Fund Strategic Investment Signing Ceremony Successfully Held
On December 10th, the signing ceremony of E-nitiate Biopharmaceuticals settlement and Betta fund strategic investment was successfully held in Yuhang District, Hangzhou. Zhu Zhenwei, member of the Standing Committee of Yuhang District Party committee, Secretary of the Party Working Committee and director of the Management Committee of the Development Zone, Dr. Ding lieming, chairman and CEO of Betta pharmaceutical and founder of Betta fund, and Dr. Shen Wang, chairman and chief scientist of E-nitiate Biopharmaceuticals attended the ceremony.
More
October 29,2021E-nitiate Biopharmaceuticals QY201 Tablet Was Approved for Clinical Trial in The Treatment of Atopic DermatitisRecently, E-nitiate Biopharmaceuticals received the"Drug Clinical Trial Approval Notice"issued by CDE(Notice No. :2021LP01713), QY201 tablet was approved for clinical trial in the treatment of atopic dermatitis.More
December 11,2020New Project Dynamics ｜ E-nitiate Biopharmaceuticals Settlement and Betta Fund Strategic Investment Signing Ceremony Successfully HeldOn December 10th, the signing ceremony of E-nitiate Biopharmaceuticals settlement and Betta fund strategic investment was successfully held in Yuhang District, Hangzhou. Zhu Zhenwei, member of the Standing Committee of Yuhang District Party committee, Secretary of the Party Working Committee and director of the Management Committee of the Development Zone, Dr. Ding lieming, chairman and CEO of Betta pharmaceutical and founder of Betta fund, and Dr. Shen Wang, chairman and chief scientist of E-nitiate Biopharmaceuticals attended the ceremony.More
